GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (FRA:4QG) » Definitions » E10

PCI Biotech Holding ASA (FRA:4QG) E10 : €0.00 (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PCI Biotech Holding ASA's adjusted earnings per share data for the three months ended in Jun. 2024 was €0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Jun. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of PCI Biotech Holding ASA was -4.60% per year. The lowest was -5.80% per year. And the median was -5.20% per year.

As of today (2024-12-13), PCI Biotech Holding ASA's current stock price is €0.1108. PCI Biotech Holding ASA's E10 for the quarter that ended in Jun. 2024 was €0.00. PCI Biotech Holding ASA's Shiller PE Ratio of today is .


PCI Biotech Holding ASA E10 Historical Data

The historical data trend for PCI Biotech Holding ASA's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA E10 Chart

PCI Biotech Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.19 -0.19 -0.23 -0.17 -

PCI Biotech Holding ASA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.16 -0.20 - -

Competitive Comparison of PCI Biotech Holding ASA's E10

For the Biotechnology subindustry, PCI Biotech Holding ASA's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PCI Biotech Holding ASA's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's Shiller PE Ratio falls into.



PCI Biotech Holding ASA E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PCI Biotech Holding ASA's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0/133.8000*133.8000
=0.000

Current CPI (Jun. 2024) = 133.8000.

PCI Biotech Holding ASA Quarterly Data

per share eps CPI Adj_EPS
201403 -0.086 97.300 -0.118
201406 -0.089 97.500 -0.122
201409 -0.091 98.500 -0.124
201412 -0.102 98.600 -0.138
201503 -0.055 99.200 -0.074
201506 -0.035 100.100 -0.047
201509 -0.046 100.600 -0.061
201512 -0.041 100.900 -0.054
201603 -0.047 102.500 -0.061
201606 -0.062 103.800 -0.080
201609 -0.063 104.200 -0.081
201612 -0.045 104.400 -0.058
201703 -0.044 105.000 -0.056
201706 -0.027 105.800 -0.034
201709 -0.044 105.900 -0.056
201712 -0.065 106.100 -0.082
201803 -0.061 107.300 -0.076
201806 -0.030 108.500 -0.037
201809 -0.034 109.500 -0.042
201812 -0.005 109.800 -0.006
201903 -0.063 110.400 -0.076
201906 -0.073 110.600 -0.088
201909 -0.038 111.100 -0.046
201912 -0.068 111.300 -0.082
202003 0.011 111.200 0.013
202006 -0.073 112.100 -0.087
202009 -0.053 112.900 -0.063
202012 -0.067 112.900 -0.079
202103 -0.063 114.600 -0.074
202106 -0.048 115.300 -0.056
202109 -0.056 117.500 -0.064
202112 -0.123 118.900 -0.138
202203 -0.063 119.800 -0.070
202206 -0.038 122.600 -0.041
202209 -0.028 125.600 -0.030
202212 -0.017 125.900 -0.018
202303 -0.014 127.600 -0.015
202306 -0.013 130.400 -0.013
202312 0.000 131.900 0.000
202406 0.000 133.800 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


PCI Biotech Holding ASA  (FRA:4QG) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PCI Biotech Holding ASA E10 Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


PCI Biotech Holding ASA Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, N-0379
PCI Biotech Holding ASA is a biopharmaceutical company focused on developing and commercializing cancer therapies using its photochemical internalization (PCI) technology platform. The PCI technology utilizes light to trigger the release of compounds from within cellular compartments. The company applies PCI to three different approaches for cancer treatment: fimaCHEM: Enhancing chemotherapeutic drugs for localized cancer treatment. fimaVACC: Inducing T-cell responses for therapeutic cancer vaccination. fimaNAc: Delivering nucleic acid therapeutics. The key product candidate is fimaporfin (Amphinex), a photosensitizer that can unlock intracellular compartments where active compounds are trapped. The company's sole operating segment is research and development.

PCI Biotech Holding ASA Headlines

No Headlines